Challenges in the Assessment and Management of Urinary Symptoms

Released On
April 5, 2019

Expires On
April 5, 2020

Media Type

Completion Time
60 minutes

Family/General Practice, Geriatrics, Gynecology, Internal Medicine, Nursing, Primary Care, Urology

Scroll to the Bottom of this Information to Begin this Course

Sponsored by The Academy for Continued Healthcare Learning (ACHL).


This activity is supported by an educational grant from Astellas Scientific & Medical Affairs.

Target Audience

This activity is intended for primary care providers including MDs, DOs, NPs, PAs and other healthcare providers involved in the treatment of patients with urinary concerns/symptoms.

Program Overview

The activity is designed to engage clinicians in an environment that supports best practices in clinical skills, health literacy and participatory medicine. The goal is to provide clinically focused education on the diagnosis and management of patients with OAB. Specific topics include: the male patient, differential diagnosis, having difficult discussions, and determining best treatment options.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Perform a differential diagnosis in OAB considering underlying medical conditions and prostate involvement in men
  • Formulate patient-specific behavioral and/or pharmacologic interventions to ensure tolerability and adherence
  • Compare and contrast the mechanisms of actions, delivery routes, efficacy, and tolerability of pharmacologic interventions for the management of overactive bladder
  • Assess when an escalation in therapy may be needed, as well as potential approaches to combination drug therapy
  • Educate and assist patients with OAB who are incorporating behavioral or pharmacologic interventions into their regimen

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)
  • Nurses — ACHL is authorized by IACET to offer 0.1 CEU for this program.

All other healthcare professionals completing this course will be issued a certificate of participation.


Scott A. MacDiarmid, MD, FRCPSC

Director, Bladder Control and Pelvic Pain Center
Alliance Urology Specialists
Greensboro, NC

Accreditation Statement

The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Academy for Continued Healthcare Learning (ACHL) has been accredited as an Authorized Provider by the International Association for Continuing Education and Training (IACET). In obtaining this accreditation, the ACHL has demonstrated that it complies with the ANSI/IACET Standard which is recognized internationally as a standard of good practice. As a result of the Authorized Provider status, ACHL is authorized to offer IACET CEUs for programs that qualify under the ANSI/IACET Standard.

Credit Designation

The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACHL is authorized by IACET to offer 0.1 CEU for this program. IACET CEUs are accepted by the American Nurses Association. Contact your licensing agency for details.

Financial Disclosures

The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME/CE activity.

Scott A. MacDiarmid, MD, FRCPSC (Chair)

  • Advisory Board/Consulting Agreements/Speakers Bureau: Avadel Pharmaceuticals, Allergan, Astellas Pharma US, and LABORIE

ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

Disclosure of Unlabeled Use

Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None

This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.

Method of Participation

This activity will take approximately 60 minutes to complete. To receive credit, participants are required to view the online simulations and complete an evaluation form. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.

For questions about this activity, please contact Katlyn Cooper at

Hardware and Software Requirements

This site is best viewed with an HTML5 compatible browser; this list includes the versions of Mircrosoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentations, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player.


The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.

This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.